Copyright © 2003 by the European Society of Cardiology.
Regular Articles
Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus
Clinic for Internal Medicine III, Friedrich-Schiller-University, Jena, Germany
* Correspondence: Gerald S. Werner, MD, Klinik für Innere Medizin III, Friedrich-Schiller-University, Erlanger Allee 101, D-07740 Jena, Germany. Tel: 1149-3641-939538; fax: 1149-3641-939363
E-mail address: gerald.werner{at}med.uni-jena.de
Received 3 October 2002; revised 7 December 2002; accepted 21 February 2003
Background The mortality of coronary artery disease is increased in diabetic patients. An impaired collateral function is considered a possible explanation. This study should assess the influence of diabetes on collaterals by direct invasive assessment of collateral function.
Methods In 90 consecutive patients with a chronic coronary occlusion (TCO) of >2 weeks duration a recanalization was done. Thirty patients with diabetes (33%) were compared with 60 (67%) without diabetes. Blood flow velocity and pressure were measured distal to the occlusion by intracoronary Doppler and pressure wires before PTCA, and again after PTCA during a final balloon reocclusion to assess acute recruitment of collaterals. Resistance indexes for collaterals (RColl) and peripheral microcirculation (RP) were calculated.
Results The RColl(diabetics: 8.1±6.8 vs nondiabetics: 8.7±6.7mmHgcm1s1; p=0.68) and RP(5.6±4.2 vs 6.6±3.8mmHgcm1s1; p=0.30) were similar in diabetic and nondiabetic patients before recanalization. During balloon reocclusion both RColland RPincreased. This increase was significantly more pronounced in diabetic than in nondiabetic patients in TCOs <3 months duration. In TCOs of longer duration (
3 months) these differences were no longer detectable between both patient groups.
Conclusions Diabetic patients with TCOs have similarly developed collaterals as nondiabetic patients. However, in TCOs <3 months duration the acute recruitment of collaterals in case of reocclusion is impaired. This could explain some of the higher complication rate and mortality after coronary interventions in diabetic patients.
Key Words: Chronic coronary occlusion Collateral circulation Diabetes mellitus Percutaneoustransluminal angioplasty Intracoronary Doppler
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. Tchaikovski, G. Fellbrich, and J. Waltenberger The Molecular Basis of VEGFR-1 Signal Transduction Pathways in Primary Human Monocytes Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 322 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berry, J.-C. Tardif, and M. G. Bourassa Coronary Heart Disease in Patients With Diabetes: Part I: Recent Advances in Prevention and Noninvasive Management J. Am. Coll. Cardiol., February 13, 2007; 49(6): 631 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stadler, J. Eggermann, S. Voo, A. Kranz, and J. Waltenberger Smoking-Induced Monocyte Dysfunction Is Reversed by Vitamin C Supplementation In Vivo Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 120 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zimarino, A. Ausiello, G. Contegiacomo, I. Riccardi, G. Renda, C. Di Iorio, and R. De Caterina Rapid Decline of Collateral Circulation Increases Susceptibility to Myocardial Ischemia: The Trade-Off of Successful Percutaneous Recanalization of Chronic Total Occlusions J. Am. Coll. Cardiol., July 4, 2006; 48(1): 59 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Zbinden, S Zbinden, M Billinger, S Windecker, B Meier, and C Seiler Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy Heart, October 1, 2005; 91(10): 1289 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Olijhoek, J. Koerselman, P. P.Th. de Jaegere, M. C. Verhaar, D. E. Grobbee, Y. van der Graaf, F. L.J. Visseren, and for the SMART Study Group Presence of the Metabolic Syndrome Does Not Impair Coronary Collateral Vessel Formation in Patients With Documented Coronary Artery Disease Diabetes Care, March 1, 2005; 28(3): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, G. W. Stone, T. D. Stuckey, C. O. Costantini, P. J. Zimetbaum, M. McLaughlin, R. Mehran, E. Garcia, J. E. Tcheng, D. A. Cox, et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction J. Am. Coll. Cardiol., February 15, 2005; 45(4): 508 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Waltenberger Growth factor signal transduction defects in the cardiovascular system Cardiovasc Res, February 15, 2005; 65(3): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Werner, E. Jandt, A. Krack, G. Schwarz, O. Mutschke, F. Kuethe, M. Ferrari, and H. R. Figulla Growth Factors in the Collateral Circulation of Chronic Total Coronary Occlusions: Relation to Duration of Occlusion and Collateral Function Circulation, October 5, 2004; 110(14): 1940 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.H. Tayebjee, G.Y.H. Lip, and R.J. MacFadyen Collateralization and the response to obstruction of epicardial coronary arteries QJM, May 1, 2004; 97(5): 259 - 272. [Abstract] [Full Text] [PDF] |
||||






